What is Cryofocus Medtech (Shanghai) Co EV-to-EBITDA?
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Cryofocus Medtech (Shanghai) Co's enterprise value is HK$1,524.44 Mil.
Cryofocus Medtech (Shanghai) Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-110.16 Mil. Therefore, Cryofocus Medtech (Shanghai) Co's EV-to-EBITDA for today is -13.84.
The historical rank and industry rank for Cryofocus Medtech (Shanghai) Co's EV-to-EBITDA or its related term are showing as below:
HKSE:06922'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -34.25 Med: -29.76 Max: -11.75
Current: -13.93
During the past 4 years, the highest EV-to-EBITDA of Cryofocus Medtech (Shanghai) Co was -11.75. The lowest was -34.25. And the median was -29.76.
HKSE:06922's EV-to-EBITDA is ranked worse than 100% of 486
companies
in the Medical Devices & Instruments industry
Industry Median: 16.14
vs HKSE:06922: -13.93
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Cryofocus Medtech (Shanghai) Co EV-to-EBITDA Chart
Competitive Comparison of Cryofocus Medtech (Shanghai) Co's EV-to-EBITDA
For the Medical Devices subindustry, Cryofocus Medtech (Shanghai) Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cryofocus Medtech (Shanghai) Co's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Cryofocus Medtech (Shanghai) Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Cryofocus Medtech (Shanghai) Co's EV-to-EBITDA falls into.
Cryofocus Medtech (Shanghai) Co EV-to-EBITDA Calculation
Cryofocus Medtech (Shanghai) Co's current Enterprise Value is HK$1,524.44 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cryofocus Medtech (Shanghai) Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-110.16 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cryofocus Medtech (Shanghai) Co (HKSE:06922) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Cryofocus Medtech (Shanghai) Co's PE Ratio for today is calculated as:
Cryofocus Medtech (Shanghai) Co's share price for today is HK$6.80.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cryofocus Medtech (Shanghai) Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-0.449.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Cryofocus Medtech (Shanghai) Co EV-to-EBITDA Related Terms
Thank you for viewing the detailed overview of Cryofocus Medtech (Shanghai) Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Cryofocus Medtech (Shanghai) Co (HKSE:06922) Business Description
Cryofocus Medtech (Shanghai) Co Ltd is a medical device company engaged in the research and development, manufacture and sale of cryoablation minimally-invasive interventional treatment technology and related medical products. It has two Core Products, the Bladder Cryoablation System and the Endoscopic Clip for Anastomosis. The Bladder Cryoablation System is a cryotherapy device designed for the treatment of bladder cancer. The Endoscopic Clip for Anastomosis is an anastomotic device for the closure of soft tissue in the digestive tract, which is one of the over-the-scope clips. Geographically company's key revenue is generated from China.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:06922 has been successfully added to your